EP Patent

EP4603084A4 — ORALLY SOLUBLE AMBROXOL FILM COMPOSITION, MANUFACTURING METHOD THEREOF AND USES THEREOF

Assigned to Shanghai Aurora Biotechnology Co Ltd · Expires 2026-01-21 · 0y expired

What this patent protects

Patent listed against Zofran.

Drugs covered by this patent

Zofran (ondansetron) · GSK (originally Glaxo)

Patent Metadata

Patent number: EP4603084A4
Jurisdiction: EP
Classification: —
Expires: 2026-01-21
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Aurora Biotechnology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.